Displaying drugs 10076 - 10100 of 10948 in total
Gotistobart
Gotistobart is under investigation in clinical trial NCT05671510 (ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors).
Investigational
Matched Description: … Gotistobart is under investigation in clinical trial NCT05671510 (ONC-392 Versus Docetaxel in Metastatic …
Naftopidil
Naftopidil has been investigated for the treatment of Disorder of Urinary Stent.
Investigational
Matched Description: … Naftopidil has been investigated for the treatment of Disorder of Urinary Stent. …
beta-Sitosterol
Active fraction of Solanum trilobatum; reduces side-effects of radiation-induced toxicity.
Experimental
Matched Iupac: … 2-yl]-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,6H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7- …
Matched Description: … Active fraction of Solanum trilobatum; reduces side-effects of radiation-induced toxicity. …
Matched Description: … Active fraction of Solanum trilobatum; reduces side-effects of radiation-induced toxicity. …
APG-157
APG-157 consists of zinflavonoids being investigated for the treatment of cancers.
Investigational
Nutraceutical
Matched Description: … APG-157 consists of zinflavonoids being investigated for the treatment of cancers. …
Isopentane
Isopentane is under investigation in clinical trial NCT00752089 (Experimental Dentifrice Remineralization/fluoride Uptake in an in Situ Model).
Investigational
Matched Description: … /fluoride Uptake in an in Situ Model). ... Isopentane is under investigation in clinical trial NCT00752089 (Experimental Dentifrice Remineralization …
Avdoralimab
Avdoralimab is under investigation in clinical trial NCT04333914 (Prospective Study in Patients With Advanced or Metastatic Cancer and Sars-cov-2 Infection).
Investigational
Matched Description: … Avdoralimab is under investigation in clinical trial NCT04333914 (Prospective Study in Patients With …
3-Allylfentanyl
3-allyfentanyl is a fentanyl derivative opioid that can cause itching, nausea and serious respiratory depression. Fentanyl and its analogs have killed thousands of people around the world as drugs of abuse.
Illicit
Matched Description: … Fentanyl and its analogs have killed thousands of people around the world as drugs of abuse. …
Debamestrocel
Debamestrocel consists of autologous mesenchymal stromal cells secreting neurotrophic factors. Debamestrocel is under clinical development by BrainStorm Cell Therapeutics and is being investigated for the treatment of Amyotrophic Lateral Sclerosis (ALS).
Investigational
Matched Description: … Debamestrocel consists of autologous mesenchymal stromal cells secreting neurotrophic factors. ... under clinical development by BrainStorm Cell Therapeutics and is being investigated for the treatment of …
IMCY-0141
IMCY-0141 is a synthetic peptide based on MOG (Myelin Oligodendrocyte Glycoprotein), a dominant autoantigen, designed to stop the progression of multiple sclerosis (MS) and the destruction of the myelin sheath protecting the nerves.
Investigational
Matched Description: … multiple sclerosis (MS) and the destruction of the myelin sheath protecting the nerves. ... MOG (Myelin Oligodendrocyte Glycoprotein), a dominant autoantigen, designed to stop the progression of …
18-methoxycoronaridine
18-methoxycoronaridine is under investigation in clinical trial NCT03084952 (Phase 2 Trial to Evaluate 18-Methoxycoronaridine Efficacy, Safety and Tolerability in Cutaneous Leishmaniasis Patients).
Investigational
Matched Description: … 18-Methoxycoronaridine Efficacy, Safety and Tolerability in Cutaneous Leishmaniasis Patients). ... 18-methoxycoronaridine is under investigation in clinical trial NCT03084952 (Phase 2 Trial to Evaluate …
Sulopenem
Sulopenem is under investigation in clinical trial NCT03357614 (Sulopenem Followed by Sulopenem-etzadroxil/Probenecid vs Ertapenem Followed by Cipro for Complicated UTI in Adults).
Investigational
Matched Iupac: … (1R,3S)-3-{[(5R,6S)-2-carboxy-6-[(1R)-1-hydroxyethyl]-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-en-3-yl] …
Matched Description: … /Probenecid vs Ertapenem Followed by Cipro for Complicated UTI in Adults). ... Sulopenem is under investigation in clinical trial NCT03357614 (Sulopenem Followed by Sulopenem-etzadroxil …
Matched Description: … /Probenecid vs Ertapenem Followed by Cipro for Complicated UTI in Adults). ... Sulopenem is under investigation in clinical trial NCT03357614 (Sulopenem Followed by Sulopenem-etzadroxil …
Disaccharide tripeptide glycerol dipalmitoyl
Disaccharide tripeptide glycerol dipalmitoyl is under investigation in clinical trial NCT00003667 (Combination Chemotherapy and Biological Therapy in Treating Patients With High-Risk Ewing's Sarcoma).
Investigational
Matched Description: … Chemotherapy and Biological Therapy in Treating Patients With High-Risk Ewing's Sarcoma). ... Disaccharide tripeptide glycerol dipalmitoyl is under investigation in clinical trial NCT00003667 (Combination …
Trastuzumab duocarmazine
Trastuzumab duocarmazine is under investigation in clinical trial NCT03262935 (SYD985 vs. Physician's Choice in Participants With Her2-positive Locally Advanced or Metastatic Breast Cancer).
Investigational
Matched Description: … Trastuzumab duocarmazine is under investigation in clinical trial NCT03262935 (SYD985 vs. ... Physician's Choice in Participants With Her2-positive Locally Advanced or Metastatic Breast Cancer). …
SEP-363856
SEP-363856 is a novel psychotropic drug being investigated for the treatment of schizophrenia. Unlike other drugs used for this condition, SEP-363856 does not bind to the dopamine D2 receptors, but exerts actions on the trace amine–associated receptor 1 (TAAR1) and 5-hydroxytryptamine type 1A (5-HT1A). SEP-363856 was developed by Sunovion pharmaceuticals....
Investigational
Matched Iupac: … methyl({[(7S)-4H,5H,7H-thieno[2,3-c]pyran-7-yl]methyl})amine …
Matched Description: … Additional clinical trials of SEP-363856 are required to confirm the safety and efficacy of this drug ... SEP-363856 is a novel psychotropic drug being investigated for the treatment of schizophrenia. ... initial clinical study has shown this drug may be effective against both positive and negative symptoms of …
Matched Description: … Additional clinical trials of SEP-363856 are required to confirm the safety and efficacy of this drug ... SEP-363856 is a novel psychotropic drug being investigated for the treatment of schizophrenia. ... initial clinical study has shown this drug may be effective against both positive and negative symptoms of …
D-Glutamic Acid
Glutamic acid is the most common excitatory neurotransmitter in the central nervous system.
Experimental
Matched Description: … Glutamic acid is the most common excitatory neurotransmitter in the central nervous system. …
Epitizide
Epitizide is an agent, commonly found in combination triamterene, used to produce diuresis.
Experimental
Matched Iupac: … chloro-1,1-dioxo-3-{[(2,2,2-trifluoroethyl)sulfanyl]methyl}-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7- …
Matched Description: … Epitizide is an agent, commonly found in combination [triamterene], used to produce diuresis. …
Matched Description: … Epitizide is an agent, commonly found in combination [triamterene], used to produce diuresis. …
Neopterin
Neopterin is under investigation in clinical trial NCT02974192 (Neopterin Effects on Ischemic Stroke).
Investigational
Matched Description: … Neopterin is under investigation in clinical trial NCT02974192 (Neopterin Effects on Ischemic Stroke) …
Amylose
Amylose is under investigation in clinical trial NCT01027325 (Resistant Starch Insulin Sensitivity Trial).
Investigational
Matched Description: … Amylose is under investigation in clinical trial NCT01027325 (Resistant Starch Insulin Sensitivity Trial …
Necuparanib
Necuparanib is under investigation in clinical trial NCT01621243 (M402 in Combination With Nab-paclitaxel and Gemcitabine in Pancreatic Cancer).
Investigational
Matched Description: … Necuparanib is under investigation in clinical trial NCT01621243 (M402 in Combination With Nab-paclitaxel ... and Gemcitabine in Pancreatic Cancer). …
Ramiprilat
The active metabolite of the prodrug Ramipril.
Experimental
Matched Description: … The active metabolite of the prodrug [Ramipril]. …
Trandolaprilat
The active metabolite of the prodrug Trandolapril.
Experimental
Matched Description: … The active metabolite of the prodrug [Trandolapril]. …
Moexiprilat
The active metabolite of the prodrug Moexipril.
Experimental
Matched Description: … The active metabolite of the prodrug [Moexipril]. …
Perindoprilat
The active metabolite of the prodrug Perindopril.
Experimental
Matched Description: … The active metabolite of the prodrug [Perindopril]. …
GBR-12783
A selective inhibitor of dopamine uptake.
Investigational
Matched Description: … A selective inhibitor of dopamine uptake.[A252997] …
Betameprodine
Betameprodine is an opioid analgesic classified by the United States Drug Enforcement Administration under Schedule I of illegal substances. The stereoisomer alphameprodine is similarly classified, and was more widely used (both are referred to as Meprodine). Betameprodine is a structural analogue of meperidine. It exerts physiological effects characteristic of opioids,...
Experimental
Illicit
Matched Description: … Betameprodine is a structural analogue of meperidine. ... an opioid analgesic classified by the United States Drug Enforcement Administration under Schedule I of ... It exerts physiological effects characteristic of opioids, such as analgesia, euphoria and sedation, …
Displaying drugs 10076 - 10100 of 10948 in total